Literature DB >> 9583200

Should children with infection be tested for lipid, lipoprotein and apolipoprotein?

A Işcan1, R Yiğitoğlu, A Onağ, N Vurgun, Z Ari, P Ertan, A Z Sengil.   

Abstract

The lipid profile is known to alter in patients with infection, but there has not been a study of the apolipoprotein levels in serum of otherwise healthy children during infection. Lipids, lipoproteins, apolipoproteins A-1 and B and lipoprotein (a) were evaluated prospectively in 31 consecutive children, aged 4-15 years, who were admitted to the hospital with bacterial pharyngitis. The degree of dyslipidemia associated with bacterial pharyngitis was assessed using each child as his/her own control and by comparison with 79 healthy children who had not had an infection during the past 3 months. Serum total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein A-1 and apolipoprotein B levels were significantly decreased during the symptomatic phase of the disease, whereas the serum triglyceride level was slightly elevated. Serum lipoprotein (a) concentration did not change significantly. In conclusion, it is suggested that serum lipids, lipoproteins and apolipoproteins should not be assessed during infection because of the possible transient changes of these parameters during infection or inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9583200     DOI: 10.1111/j.1442-200x.1998.tb01401.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  2 in total

1.  Evaluation of Lipid Profile Changes in Pediatric Patients with Acute Mononucleosis.

Authors:  Shirin Sayyahfar; Amin Lavasani; Alireza Nateghian; Abdollah Karimi
Journal:  Infect Chemother       Date:  2017-03-13

Review 2.  A young infant with transient severe hypertriglyceridemia temporarily associated with meropenem administration: A case report and review of the literature.

Authors:  Susanna Esposito; Raffaella Pinzani; Genny Raffaeli; Tiziano Lucchi; Carlo Agostoni; Nicola Principi
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.